MetaADEDB 2.0 @ LMMD
rotigotine
(KFQYTPMOWPVWEJ-UHFFFAOYSA-N)
Structure
SMILES
CCCN(C1CCc2c(C1)cccc2O)CCc1cccs1
Molecular Formula:
C19H25NOS
Molecular Weight:
315.473
Log P:
4.2657
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
1
TPSA:
51.71
CAS Number(s):
92206-54-7; 112835-48-0
Synonym(s)
1.
rotigotine
2.
(+)-5,6,7,8-tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-1-naphthol
3.
(+--)-5,6,7,8-tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-1-naphthol
4.
1-naphthalenol, 5,6,7,8-tetrahydro-6-(propyl(2-(2-thienyl)ethyl)amino)-
5.
2-(N-n-propyl-N-2-thienylethylamino)-5-hydroxytetralin
6.
N 0437
7.
N 0437, (+-)-isomer
8.
N 0437, (-)-isomer
9.
N 0437, (R)-isomer
10.
N 0437, hydrochloride, (R)-isomer
11.
N 0437, hydrochloride, (S)-isomer
12.
N 0923
13.
N 0924
14.
N-0437
15.
N-0923
16.
N-0924
17.
Neupro
18.
Rotigotine CDS
19.
racemic N-0437
20.
rotigotine (+-)-form
21.
rotigotine, (+)-
22.
rotigotine, (+--)-
External Link(s)
MeSHC047508
PubChem Compound57537
BindingDB50054062
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AbasiaOFFSIDES
2Accidental exposureOFFSIDES
3Acute myocardial infarctionOFFSIDES
4AmphetaminesOFFSIDES
5AnosmiaOFFSIDES
6Application site burnOFFSIDES
7Application site drynessOFFSIDES
8Application site eczemaOFFSIDES
9Application site erosionOFFSIDES
10Application site erythemaOFFSIDES
11Application site exfoliationOFFSIDES
12Application site hypersensitivityOFFSIDES
13Application site irritationOFFSIDES
14Application site painOFFSIDES
15Application site pruritusOFFSIDES
16Application site rashOFFSIDES
17Application site reactionOFFSIDES
18Application site scabOFFSIDES
19Application site scarOFFSIDES
20Application site swellingOFFSIDES
21Application site ulcerOFFSIDES
22Application site urticariaOFFSIDES
23Application site vesiclesOFFSIDES
24Application site warmthOFFSIDES
25AtelectasisOFFSIDES
26Blurred visionOFFSIDES
27BradycardiaOFFSIDES
28Brain ConcussionOFFSIDES
29Contact DermatitisOFFSIDES
30Corneal UlcerOFFSIDES
31DemyelinationOFFSIDES
32DiplopiaOFFSIDES
33DizzinessOFFSIDES
34Drug administration errorOFFSIDES
35Drug dispensing errorOFFSIDES
36Drug dose omissionOFFSIDES
37Drug ineffectiveOFFSIDES
38Dysthymic DisorderOFFSIDES
39Electrocardiogram repolarisation abnormalityOFFSIDES
40ErythemaOFFSIDES
41ExcoriationOFFSIDES
42Expired drug administeredOFFSIDES
43FatigueOFFSIDES
44Febrile NeutropeniaOFFSIDES
45Feeling abnormalOFFSIDES
46Fibrin increasedOFFSIDES
47Freezing phenomenonOFFSIDES
48GranulomaOFFSIDES
49Grip strengthOFFSIDES
50Hallucinations, mixedOFFSIDES
51HypervigilanceOFFSIDES
52HypogeusiaOFFSIDES
53Incorrect drug administration durationOFFSIDES
54Infusion site cellulitisOFFSIDES
55Infusion site fibrosisOFFSIDES
56Infusion site mobility decreasedOFFSIDES
57Initial insomniaOFFSIDES
58Intention tremorOFFSIDES
59Intentional drug misuseOFFSIDES
60Intracranial AneurysmOFFSIDES
61LacerationOFFSIDES
62Left Ventricular HypertrophyOFFSIDES
63LethargyOFFSIDES
64MeningiomaOFFSIDES
65Mental status changes postoperativeOFFSIDES
66MonoparesisOFFSIDES
67Musculoskeletal stiffnessOFFSIDES
68NauseaOFFSIDES
69Open reduction of fractureOFFSIDES
70Pain of skinOFFSIDES
71Perirectal abscessOFFSIDES
72Pharmaceutical product complaintOFFSIDES
73Poor quality drug administeredOFFSIDES
74Product quality issueOFFSIDES
75Pulmonary InfarctionOFFSIDES
76Pulmonary thrombosisOFFSIDES
77Skin IndurationOFFSIDES
78Sleep TalkingOFFSIDES
79SoliloquyOFFSIDES
80Spinal column stenosisOFFSIDES
81Sudden Cardiac DeathOFFSIDES
82Superficial ThrombophlebitisOFFSIDES
83Therapeutic response unexpectedOFFSIDES
84Tongue blisteringOFFSIDES
85Traumatic fractureOFFSIDES
86Unevaluable eventOFFSIDES
87Wrong technique in drug usage processOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.